Jude Onyia
Chief Tech/Sci/R&D Officer at NEUROCRINE BIOSCIENCES, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Jude Onyia is currently the Director at Voyager Therapeutics, Inc. and the Chief Scientific Officer at Neurocrine Biosciences, Inc. Prior to his current roles, he worked at Eli Lilly & Co. for 26 years, where he held the position of Vice President-Biotechnology Discovery Research from 2014 to 2021.
He also briefly served as the Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Onyia received his undergraduate degree from The State University of New York and his doctorate from the State University of New York at Downstate Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-12 | 13,128 ( 0.01% ) | 2 M $ | 2024-03-30 | |
| 2023-06-05 | 2,910 ( 0.01% ) | 27 092 $ | 2024-03-30 |
Jude Onyia active positions
| Companies | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-11-29 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Former positions of Jude Onyia
| Companies | Position | End |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2021-05-31 |
Training of Jude Onyia
| The State University of New York | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
- Stock Market
- Insiders
- Jude Onyia
